Psagot Value Holdings’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Psagot Value Holdings’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1	Closed	-$4K	–	362
2018 Q1	$4K	Hold	1	–	–	﹤0.01%	325
2017 Q4	$4K	Sell	1 -4	-80%	-$18.3K	﹤0.01%	289
2017 Q3	$23K	Sell	5 -6	-55%	-$30.9K	﹤0.01%	281
2017 Q2	$61K	Buy	11 +10	+1,000%	+$54.9K	﹤0.01%	253
2017 Q1	$6K	Buy	+1	New	+$6.07K	﹤0.01%	312

Other funds holding CANF

TAM

Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

TDC

Thompson Davis & Co Richmond, Virginia $150M AUM 32.35% 1-Year Est. Return

Advisornet Financial Minnetonka, Minnesota $1.93B AUM 18.43% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Psagot Value Holdings's CANF Position: Q2 2018 in Review

Psagot Value Holdings sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q2 2018, closing a stake of 1 share — an estimated $4K sold.

Psagot Value Holdings first reported a position in CANF in Q1 2017 and held it in 5 quarters. The position peaked at $61K in Q2 2017. 11 funds tracked by Wall St. Rank hold CANF as of Q2 2018.

Psagot Value Holdings reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q2 2018 after selling out during the quarter.
Psagot Value Holdings sold 1 Can-Fite BioPharma American Depositary Shares share in Q2 2018, an estimated $4K.
Psagot Value Holdings first reported a position in Can-Fite BioPharma American Depositary Shares in Q1 2017 and held it in 5 quarters.
Psagot Value Holdings's Can-Fite BioPharma American Depositary Shares position peaked at $61K in Q2 2017.
11 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q2 2018.

Based on Psagot Value Holdings's 13F filing for Q2 2018, filed 1 Aug 2018.